Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
CC

Chemours Co-The

CC

28.72USD-0.86 (-2.91%)Market Closed
Watchlist

Market Summary

USD28.72-0.86
Market Closed
-2.91%

CC Alerts

  • Big fall in Revenue (Y/Y)
  • Big fall in earnings (Y/Y)

CC Stock Price

View Fullscreen

CC RSI Chart

CC Valuation

Market Cap

4.4B

Price/Earnings (Trailing)

-14.25

Price/Sales (Trailing)

0.73

EV/EBITDA

19.02

Price/Free Cashflow

-62.72

CC Price/Sales (Trailing)

CC Profitability

EBT Margin

-5.10%

Return on Equity

-40.69%

Return on Assets

-3.88%

Free Cashflow Yield

-1.59%

CC Fundamentals

CC Revenue

Revenue (TTM)

6.0B

Revenue Y/Y

-16.32%

Revenue Q/Q

-9.49%

CC Earnings

Earnings (TTM)

-308.0M

Earnings Y/Y

-91.67%

Earnings Q/Q

105.32%

Price Action

Last 7 days

13.0%

Last 30 days

15.2%

Last 90 days

-11.9%

Trailing 12 Months

-5.7%

How does CC drawdown profile look like?

CC Financial Health

Current Ratio

1.68

CC Investor Care

Dividend Yield

3.38%

Dividend/Share (TTM)

1

Buy Backs (1Y)

3.08%

Diluted EPS (TTM)

-1.99

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20236.6B6.3B6.0B0
20226.7B6.9B7.0B6.8B
20215.1B5.7B6.1B6.3B
20205.5B5.1B5.0B5.0B
20196.3B5.9B5.6B5.5B
20186.5B6.7B6.7B6.6B
20175.5B5.7B5.9B6.2B
20165.7B5.5B5.4B5.4B
20156.2B6.1B5.9B5.7B
20146.8B6.6B6.5B6.4B
20130006.9B

Latest Insider Trading transactions for CC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 02, 2023
charles ron christopher
sold (taxes)
-62,248
24.44
-2,547
senior vice president, people
Aug 01, 2023
dignam denise
acquired
-
-
2,712
svp, president, titanium techn
Aug 01, 2023
lock jonathan
acquired
-
-
9,224
svp, chief development officer
Aug 01, 2023
abbott matthew s
acquired
-
-
4,069
svp, chief enterprise transfor
Aug 01, 2023
familiar calderon gerardo
acquired
-
-
7,867
pres advanced performance mat
Aug 01, 2023
wellman kristine m
acquired
-
-
3,255
svp, gc & corp. secretary
Aug 01, 2023
wisel camela
acquired
-
-
5,425
vp, cao & controller
Aug 01, 2023
scarborough alvenia
acquired
-
-
6,782
svp corp communications & cbo
Aug 01, 2023
martinko joseph t.
acquired
-
-
5,154
president, thermal & specializ
Jun 09, 2023
newman mark
bought
249,978
32.6299
7,661
president and ceo

1–10 of 50

Which funds bought or sold CC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 01, 2023
B. Riley Wealth Advisors, Inc.
sold off
-100
-773,643
-
-%
Nov 30, 2023
Modera Wealth Management, LLC
unchanged
-
-93,237
295,843
0.01%
Nov 28, 2023
Dakota Community Bank & Trust NA
sold off
-100
-11,657
-
-%
Nov 27, 2023
AllSquare Wealth Management LLC
unchanged
-
18.00
1,459
-%
Nov 27, 2023
TRUST CO OF VERMONT
added
20.13
-1,903
20,084
-%
Nov 24, 2023
DEUTSCHE BANK AG\
added
4,407
47,911,900
49,351,700
0.03%
Nov 22, 2023
Aurora Investment Counsel
added
24.7
-22,863
418,563
0.28%
Nov 21, 2023
Invst, LLC
added
3.38
-176,035
646,833
0.09%
Nov 21, 2023
Walleye Capital LLC
new
-
559,822
559,822
-%
Nov 21, 2023
TOMPKINS FINANCIAL CORP
unchanged
-
-2,334
7,405
-%

1–10 of 41

Latest Funds Activity

Are funds buying CC calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CC
No. of Funds

Schedule 13G FIlings of Chemours Co-The

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Apr 10, 2023
fmr llc
-
0
SC 13G/A
Feb 14, 2023
sessa capital (master), l.p.
0.36%
547,057
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
12.20%
18,416,153
SC 13G/A
Jan 26, 2023
blackrock inc.
12.3%
18,516,903
SC 13G/A
Jan 20, 2023
blackrock inc.
12.3%
18,516,903
SC 13G/A
Apr 08, 2022
blackrock inc.
11.3%
18,075,740
SC 13G/A
Feb 14, 2022
sessa capital (master), l.p.
3.6%
5,748,120
SC 13G/A
Feb 09, 2022
vanguard group inc
9.98%
16,258,762
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G/A

Recent SEC filings of Chemours Co-The

View All Filings
Date Filed Form Type Document
Dec 04, 2023
3
Insider Trading
Nov 29, 2023
8-K
Current Report
Nov 22, 2023
8-K
Current Report
Nov 06, 2023
4
Insider Trading
Oct 27, 2023
10-Q
Quarterly Report
Oct 26, 2023
8-K
Current Report
Oct 03, 2023
4
Insider Trading
Oct 03, 2023
4
Insider Trading
Oct 03, 2023
3
Insider Trading
Sep 14, 2023
144
Notice of Insider Sale Intent

CC Fair Value

Loading...

Peers (Alternatives to Chemours Co-The)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
60.0B
12.6B
-7.90% -15.20%
26.1
4.76
-0.78% 1.95%
36.7B
45.9B
4.77% 2.31%
26.87
0.8
-22.80% -76.46%
15.4B
10.7B
16.84% 30.28%
7.58
1.44
11.66% 22.90%
14.5B
7.0B
16.77% -5.67%
39.82
2.06
-7.68% -42.97%
14.1B
9.9B
-6.31% -57.68%
4.23
1.42
76.68% 113.94%
MID-CAP
10.0B
9.4B
10.15% -3.05%
12.61
0.94
-13.99% -50.00%
4.3B
3.9B
14.58% 3.71%
9.46
1.09
-9.03% 109.45%
4.1B
926.3M
4.56% -10.31%
39.49
4.4
0.36% -5.15%
3.2B
3.2B
4.15% -0.73%
5.44
1
5.04% 214.53%
3.0B
3.2B
10.84% 8.58%
3.71
0.94
-11.97% -23.95%
SMALL-CAP
1.2B
404.0M
0.66% 31.83%
36.23
2.98
24.06% -25.72%
736.4M
1.6B
5.26% -33.56%
7.89
0.47
-20.87% -42.34%
155.0M
370.4M
-29.97% 67.32%
6.75
0.42
1.73% 194.09%
113.7M
21.4M
21.58% 17.36%
13.56
5.32
-45.68% 139.96%
14.7M
268.2M
-95.00% -99.56%
-0.02
0.05
20.46% -590.95%

Chemours Co-The News

Latest updates
Maryland Matters30 May 202307:00 am6 months ago
Plastics News02 Jul 201507:00 am8 years ago

Financials for Chemours Co-The

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue-9.5%1,4871,6431,5361,3381,7771,9151,7641,5751,6801,6551,4361,3381,2331,0931,3051,3531,3901,4081,3761,4641,628
Gross Profit-31.5%281410368202432497486393427264297313257199298150294323296400477
Operating Expenses-60.7%317806166211171280182190154204158250143147160183184162186229195
  S&GA Expenses-78.8%165779124175140254141158124172139180112110125126130136156191163
  R&D Expenses0%28.0028.0026.0031.0032.0025.0030.0029.0027.0027.0024.0027.0022.0020.0024.0019.0020.0019.0022.0022.0020.00
EBITDA Margin-56.1%0.03*0.07*0.17*0.18*0.22*0.22*0.20*0.19*0.15*0.13*0.14*0.14*0.03*0.01*0.01*------
Interest Expenses14.6%55.0048.0042.0041.0041.0040.0041.0044.0045.0047.0049.0050.0053.0053.0054.0052.0053.0052.0051.00343-47.00
Income Taxes105.3%3.00-57.0028.0028.0059.0030.0046.0069.0017.00-22.005.004.00-16.00-4.00-23.00-13715.0037.0013.0040.00-6.00
Earnings Before Taxes105.3%23.00-433173-69.0029923128030123144.0010123.0060.0020.0077.00-45491.00133107182269
EBT Margin-969.4%-0.05*0.00*0.10*0.11*0.16*0.15*0.13*0.11*0.07*0.04*0.04*0.04*-0.06*-0.05*-0.03*------
Net Income105.3%20.00-376145-97.0024020123423321466.0096.0019.0076.0024.00100-31776.0096.0094.00142275
Net Income Margin-266.9%-0.05*-0.01*0.07*0.09*0.13*0.13*0.11*0.10*0.06*0.05*0.04*0.04*-0.02*-0.02*-0.01*------
Free Cashflow1366.7%44.003.00-21093.00229229-104131244189-21.0030025250.00-62.00------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets3.8%7,9487,6607,6247,6407,7457,7307,5247,5507,5307,4797,1707,0826,9487,0346,9487,2587,4567,4337,3257,3627,512
  Current Assets9.2%3,6833,3743,2023,2143,5433,6063,3933,3453,3713,0472,7862,6332,6052,7172,5912,7772,8272,8322,8473,2933,448
    Cash Equivalents15.4%8527388161,1021,3681,3481,2451,5511,1311,1391,0081,1059561,0317149436946306971,2011,275
  Inventory-9.1%1,3141,4461,4861,4041,3211,2191,1661,0991,0161,0469889399931,0741,1141,0791,2231,2501,2181,1471,086
  Net PPE-2.2%3,1193,1903,1803,1713,0713,1113,1313,1543,1273,4483,4323,4743,4183,4233,4443,5593,5203,4913,3793,2913,207
  Goodwill0%102102102102102102102102102153152153---153----2.00-
Liabilities5.0%7,1916,8506,3966,5336,4606,5156,3576,4686,5316,5796,3186,2676,2146,3756,2876,5636,6136,6046,5096,3426,366
  Current Liabilities0.2%2,1952,1901,7451,8911,9511,8861,7751,8581,7791,6741,5011,4421,3081,1561,3431,5411,6431,4481,5721,7091,698
    LT Debt, Current------------------18.0013.0013.0014.00
    LT Debt, Non Current9.4%3,9443,6043,5993,5903,5103,6563,6923,7243,8293,9643,9704,0054,0634,3274,0124,0264,0074,1903,9653,9593,985
Shareholder's Equity-6.8%7558101,2281,1071,2851,2151,1671,0829999008528157346596616958438298161,0201,146
  Retained Earnings-1.0%1,8451,8642,2782,1702,3042,1021,9401,7461,5541,3811,3571,3031,3251,2901,3081,2491,6061,5711,5171,4661,358
  Additional Paid-In Capital1.6%1,0301,0141,0041,0161,0151,005956944926920907890879872870859857853845860856
Accumulated Depreciation-3.7%6,1246,3586,3196,2166,1156,1536,1236,0786,0806,2206,1216,1085,9735,8735,7705,8545,7545,7685,7105,7015,678
Shares Outstanding0.1%148148149149153156157161164165165165164164164164163163165171174
Minority Interest0%2.002.001.00-1.001.001.001.001.002.002.002.002.002.006.006.006.006.006.006.006.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations113.1%130,00061,000-119,000160,000301,000291,0002,000214,000311,000256,00039,000353,000299,000111,00044,000400,000288,0006,000-44,000259,000342,000
  Share Based Compensation100.0%6,0003,0004,0003,0007,0007,00010,00010,0004,0008,00012,0004,0003,0001,0008,0001,0004,0006,0008,0004,0005,000
Cashflow From Investing196.7%58,000-60,000-97,000-65,000-74,000-35,000-110,000422,000-68,000-57,000-77,000-34,000-37,000-51,000-112,000-96,000-131,000-122,000-134,000-160,000-97,000
Cashflow From Financing545.2%325,000-73,000-73,000-190,000-175,000-131,000-189,000-201,000-241,000-76,000-42,000-187,000-354,000247,000-155,000-59,000-77,00041,000-324,000-170,000-182,000
  Dividend Payments-2.6%37,00038,00037,00037,00039,00038,00040,00041,00041,00041,00041,00041,00041,00041,00041,00040,00041,00041,00042,00042,00045,000
  Buy Backs-51.4%18,00037,00014,000144,00079,000128,000144,00093,00067,00013,000-------67,000255,000124,000126,000

CC Income Statement

2023-09-30
Interim Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Net sales$ 1,487$ 1,777$ 4,666$ 5,456
Cost of goods sold1,2061,3453,6074,042
Gross profit2814321,0591,414
Selling, general, and administrative expense1651401,067535
Research and development expense28328288
Restructuring, asset-related, and other charges124(1)13910
Total other operating expenses3171711,288633
Equity in earnings of affiliates13163844
Interest expense, net(55)(41)(145)(123)
(Loss) gain on extinguishment of debt(1)7(1)7
Other income, net10256100101
Income (loss) before income taxes23299(237)810
Provision for (benefit from) income taxes359(26)135
Net income (loss)20240(211)675
Less: Net income attributable to non-controlling interests  1 
Net income (loss) attributable to Chemours$ 20$ 240$ (212)$ 675
Per share data    
Basic earnings (loss) per share of common stock$ 0.13$ 1.54$ (1.42)$ 4.3
Diluted earnings (loss) per share of common stock$ 0.13$ 1.52$ (1.42)$ 4.21

CC Balance Sheet

2023-09-30
Interim Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 852$ 1,102
Restricted cash and restricted cash equivalents595 
Accounts and notes receivable, net846626
Inventories1,3141,404
Prepaid expenses and other7682
Total current assets3,6833,214
Property, plant, and equipment9,2439,387
Less: Accumulated depreciation(6,124)(6,216)
Property, plant, and equipment, net3,1193,171
Operating lease right-of-use assets258240
Goodwill102102
Other intangible assets, net513
Investments in affiliates192175
Restricted cash and restricted cash equivalents 202
Other assets589523
Total assets7,9487,640
Current liabilities:  
Accounts payable9011,251
Compensation and other employee-related cost94121
Short-term and current maturities of long-term debt2325
Current environmental remediation138194
Other accrued liabilities1,039300
Total current liabilities2,1951,891
Long-term debt, net3,9443,590
Operating lease liabilities207198
Long-term environmental remediation467474
Deferred income taxes5461
Other liabilities324319
Total liabilities7,1916,533
Commitments and contingent liabilities
Equity  
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 197,344,369 shares issued and 148,364,181 shares outstanding at September 30, 2023; 195,375,810 shares issued and 148,504,030 shares outstanding at December 31, 2022)22
Treasury stock, at cost (48,980,188 shares at September 30, 2023; 46,871,780 shares at December 31, 2022)(1,807)(1,738)
Additional paid-in capital1,0301,016
Retained earnings1,8452,170
Accumulated other comprehensive loss(315)(343)
Total Chemours stockholders’ equity7551,107
Non-controlling interests2 
Total equity7571,107
Total liabilities and equity$ 7,948$ 7,640
CC
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
 CEO
 WEBSITEwww.chemours.com
 EMPLOYEES6600

Chemours Co-The Frequently Asked Questions


What is the ticker symbol for Chemours Co-The? What does CC stand for in stocks?

CC is the stock ticker symbol of Chemours Co-The. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Chemours Co-The (CC)?

As of Mon Dec 04 2023, market cap of Chemours Co-The is 4.39 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CC stock?

You can check CC's fair value in chart. The fair value of Chemours Co-The is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Chemours Co-The is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Chemours Co-The a good stock to buy?

The fair value guage provides a quick view whether CC is over valued or under valued. Whether Chemours Co-The is cheap or expensive depends on the assumptions which impact Chemours Co-The's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CC.

What is Chemours Co-The's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Dec 04 2023, CC's PE ratio (Price to Earnings) is -14.25 and Price to Sales (PS) ratio is 0.73. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CC PE ratio will change depending on the future growth rate expectations of investors.